A systematic review of the use of antifibrinolytic agents in pediatric surgery and implications for craniofacial use. (apre una nuova finestra)

Basta MN, Stricker PA, Taylor JA.

Fonte‎: Pediatr Surg Int 2012;28(11):1059-69.

Indicizzato‎: PubMed 22940882

DOI‎: 10.1007/s00383-012-3167-6

https://www.ncbi.nlm.nih.gov/pubmed/22940882 (apre una nuova finestra)

Use of tranexamic acid as a rescue measure to achieve hemostasis after massive blood loss in a pediatric neurosurgical patient. (apre una nuova finestra)

Bharath K, Bhagat H, Mohindra S.

Fonte‎: J Neurosurg Anesthesiol 2011;23(4):376-7.

Indicizzato‎: PubMed 21876453

DOI‎: 10.1097/ANA.0b013e31822c804f

https://www.ncbi.nlm.nih.gov/pubmed/21876453 (apre una nuova finestra)

Aprotinin, transfusions, and kidney injury in neonates and infants undergoing cardiac surgery. (apre una nuova finestra)

Bojan M, Vicca S, Boulat C, Gioanni S, Pouard P.

Fonte‎: Br J Anaesth 2012;108(5):830-7.

Indicizzato‎: PubMed 22362670

DOI‎: 10.1093/bja/aes002

https://www.ncbi.nlm.nih.gov/pubmed/22362670 (apre una nuova finestra)

A Jehovah's Witness child with hemophilia B and factor IX inhibitors undergoing scoliosis surgery. [Chirurgie de la scoliose chez un enfant Témoin de Jéhovah souffrant d’hémophilie B et présentant des inhibiteurs du facteur IX.] [English, French abstract] (apre una nuova finestra)

Chau A, Wu J, Ansermino M, Tredwell S, Purdy R.

Fonte‎: Can J Anaesth 2008;55(1):47-51.

Indicizzato‎: PubMed 18166748

DOI‎: 10.1007/BF03017597

https://www.ncbi.nlm.nih.gov/pubmed/18166748 (apre una nuova finestra)

Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study. (apre una nuova finestra)

Elwatidy S, Jamjoom Z, Elgamal E, Zakaria A, Turkistani A, El-Dawlatly A.

Fonte‎: Spine (Phila Pa 1976) 2008;33(24):2577-80.

Indicizzato‎: PubMed 19011538

DOI‎: 10.1097/BRS.0b013e318188b9c5

https://www.ncbi.nlm.nih.gov/pubmed/19011538 (apre una nuova finestra)

The efficacy of antifibrinolytic drugs in children undergoing noncardiac surgery: a systematic review of the literature. (apre una nuova finestra)

Faraoni D, Goobie SM.

Fonte‎: Anesth Analg 2014;118(3):628-36.

Indicizzato‎: PubMed 24557107

DOI‎: 10.1213/ANE.0000000000000080

https://www.ncbi.nlm.nih.gov/pubmed/24557107 (apre una nuova finestra)

The effect of Amicar on perioperative blood loss in idiopathic scoliosis: the results of a prospective, randomized double-blind study. (apre una nuova finestra)

Florentino-Pineda I, Thompson GH, Poe-Kochert C, Huang RP, Haber LL, Blakemore LC.

Fonte‎: Spine 2004;29(3):233-8.

Indicizzato‎: PubMed 14752343

https://www.ncbi.nlm.nih.gov/pubmed/14752343 (apre una nuova finestra)

A randomized control trial to verify the efficacy of pre-operative intravenous tranexamic acid in the control of tonsillectomy bleeding. (apre una nuova finestra)

George A, Kumar R, Kumar S, Shetty S.

Fonte‎: Indian J Otolaryngol Head Neck Surg 2011;63(1):20-6.

Indicizzato‎: PubMed 22319712

DOI‎: 10.1007/s12070-010-0095-4

https://www.ncbi.nlm.nih.gov/pubmed/22319712 (apre una nuova finestra)

Efficacy of tranexamic acid in pediatric craniosynostosis surgery: a double-blind, placebo-controlled trial. (apre una nuova finestra)

Goobie SM, Meier PM, Pereira LM, McGowan FX, Prescilla RP, Scharp LA, Rogers GF, Proctor MR, Meara JG, Soriano SG, Zurakowski D, Sethna NF.

Fonte‎: Anesthesiology 2011;114(4):862-71.

Indicizzato‎: PubMed 21364458

DOI‎: 10.1097/ALN.0b013e318210fd8f

https://www.ncbi.nlm.nih.gov/pubmed/21364458 (apre una nuova finestra)

Tranexamic acid is efficacious at decreasing the rate of blood loss in adolescent scoliosis surgery: a randomized placebo-controlled trial. (apre una nuova finestra)

Goobie SM, Zurakowski D, Glotzbecker MP, McCann ME, Hedequist D, Brustowicz RM, Sethna NF, Karlin LI, Emans JB, Hresko MT

Fonte‎: J Bone Joint Surg Am 2018;100(23):2024-32.

Indicizzato‎: PubMed 30516625

DOI‎: 10.2106/JBJS.18.00314

https://www.ncbi.nlm.nih.gov/pubmed/30516625 (apre una nuova finestra)

Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery. (apre una nuova finestra)

Graham EM, Atz AM, Gillis J, Desantis SM, Haney AL, Deardorff RL, Uber WE, Reeves ST, McGowan FX Jr, Bradley SM, Spinale FG.

Fonte‎: J Thorac Cardiovasc Surg 2012;143(5):1069-76.

Indicizzato‎: PubMed 22075061

DOI‎: 10.1016/j.jtcvs.2011.08.051

https://www.ncbi.nlm.nih.gov/pubmed/22075061 (apre una nuova finestra)

Anesthetic management for transfusion-free Rastelli's procedure in a pediatric Jehovah's Witness patient. (apre una nuova finestra)

Kang SH, Song I, Kang JE, Lee JH, Kim JT.

Fonte‎: Korean J Anesthesiol 2013;65(6 Suppl):S87-8.

Indicizzato‎: PubMed 24478887

DOI‎: 10.4097/kjae.2013.65.6S.S87

https://www.ncbi.nlm.nih.gov/pubmed/24478887 (apre una nuova finestra)

The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery. (apre una nuova finestra)

Lin CY, Shuhaiber JH, Loyola H, Liu H, Del Nido P, DiNardo JA, Pigula FA.

Fonte‎: PLoS One 2015;10(5):e0126514.

Indicizzato‎: PubMed 25954976

DOI‎: 10.1371/journal.pone.0126514

https://www.ncbi.nlm.nih.gov/pubmed/25954976 (apre una nuova finestra)

Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery. (apre una nuova finestra)

Martin K, Breuer T, Gertler R, Hapfelmeier A, Schreiber C, Lange R, Hess J, Wiesner G.

Fonte‎: Eur J Cardiothorac Surg 2011;39(6):892-7.

Indicizzato‎: PubMed 21115357

DOI‎: 10.1016/j.ejcts.2010.09.041

https://www.ncbi.nlm.nih.gov/pubmed/21115357 (apre una nuova finestra)

Antifibrinolytic agents reduce blood loss during pediatric vertebral column resection procedures. (apre una nuova finestra)

Newton PO, Bastrom TP, Emans JB, Shah SA, Shufflebarger HL, Sponseller PD, Sucato DJ, Lenke LG.

Fonte‎: Spine (Phila Pa 1976) 2012;37(23):E1459-63.

Indicizzato‎: PubMed 22872217

DOI‎: 10.1097/BRS.0b013e31826c9fe4

https://www.ncbi.nlm.nih.gov/pubmed/22872217 (apre una nuova finestra)

Comparative analysis of antifibrinolytic medications in pediatric heart surgery. (apre una nuova finestra)

Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Jacobs JP.

Fonte‎: J Thorac Cardiovasc Surg 2012;143(3):550-7.

Indicizzato‎: PubMed 22264414

DOI‎: 10.1016/j.jtcvs.2011.06.048

https://www.ncbi.nlm.nih.gov/pubmed/22264414 (apre una nuova finestra)

Use of tranexamic acid in infants undergoing choroid plexus papilloma surgery: a report of two cases. (apre una nuova finestra)

Phi JH, Goobie SM, Hong KH, Dholakia A, Smith ER.

Fonte‎: Paediatr Anaesth 2014;24(7):791-3.

Indicizzato‎: PubMed 24924340

DOI‎: 10.1111/pan.12447

https://www.ncbi.nlm.nih.gov/pubmed/24924340 (apre una nuova finestra)

The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: a meta-analysis. (apre una nuova finestra)

Schouten ES, van de Pol AC, Schouten AN, Turner NM, Jansen NJ, Bollen CW.

Fonte‎: Pediatr Crit Care Med 2009;10(2):182-90.

Indicizzato‎: PubMed 19188875

DOI‎: 10.1097/PCC.0b013e3181956d61

https://www.ncbi.nlm.nih.gov/pubmed/19188875 (apre una nuova finestra)

The role of Amicar in same-day anterior and posterior spinal fusion for idiopathic scoliosis. (apre una nuova finestra)

Thompson GH, Florentino-Pineda I, Poe-Kochert C, Armstrong DG, Son-Hing JP.

Fonte‎: Spine (Phila Pa 1976) 2008;33(20):2237-42.

Indicizzato‎: PubMed 18794767

DOI‎: 10.1097/BRS.0b013e31817bd889

https://www.ncbi.nlm.nih.gov/pubmed/18794767 (apre una nuova finestra)

Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation. (apre una nuova finestra)

Verma YS, Chauhan S, Bisoi AK, Gharde P, Kiran U, Das SN.

Fonte‎: Ann Card Anaesth 2010;13(2):110-5.

Indicizzato‎: PubMed 20442540

DOI‎: 10.4103/0971-9784.62935

https://www.ncbi.nlm.nih.gov/pubmed/20442540 (apre una nuova finestra)

Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass. (apre una nuova finestra)

Wesley MC, Pereira LM, Scharp LA, Emani SM, McGowan FX Jr, DiNardo JA.

Fonte‎: Anesthesiology 2015;122(4):746-58.

Indicizzato‎: PubMed 25585004

DOI‎: 10.1097/ALN.0000000000000570

https://www.ncbi.nlm.nih.gov/pubmed/25585004 (apre una nuova finestra)

Does the intraoperative tranexamic acid decrease operative blood loss during posterior spinal fusion for treatment of adolescent idiopathic scoliosis? (apre una nuova finestra)

Yagi M, Hasegawa J, Nagoshi N, Iizuka S, Kaneko S, Fukuda K, Takemitsu M, Shioda M, Machida M.

Fonte‎: Spine (Phila Pa 1976) 2012;37(21):E1336-42.

Indicizzato‎: PubMed 22772572

DOI‎: 10.1097/BRS.0b013e318266b6e5

https://www.ncbi.nlm.nih.gov/pubmed/22772572 (apre una nuova finestra)

Pediatric off-label use of recombinant factor VIIa. (apre una nuova finestra)

Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK.

Fonte‎: Pediatrics 2009;123(3):1066-72.

Indicizzato‎: PubMed 19255041

DOI‎: 10.1542/peds.2008-1685

https://www.ncbi.nlm.nih.gov/pubmed/19255041 (apre una nuova finestra)

Recombinant activated factor VII usage in life threatening hemorrhage: a pediatric experience. (apre una nuova finestra)

Bhat S, Yadav SP, Anjan M, Dinand V, Sachdeva A.

Fonte‎: Indian J Pediatr 2011;78(8):961-8.

Indicizzato‎: PubMed 21328080

DOI‎: 10.1007/s12098-011-0364-6

https://www.ncbi.nlm.nih.gov/pubmed/21328080 (apre una nuova finestra)

Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. (apre una nuova finestra)

Brady KM, Easley RB, Tobias JD.

Fonte‎: Paediatr Anaesth 2006;16(10):1042-6.

Indicizzato‎: PubMed 16972833

DOI‎: 10.1111/j.1460-9592.2006.02039.x

https://www.ncbi.nlm.nih.gov/pubmed/16972833 (apre una nuova finestra)

A Jehovah's Witness child with hemophilia B and factor IX inhibitors undergoing scoliosis surgery. [Chirurgie de la scoliose chez un enfant Témoin de Jéhovah souffrant d’hémophilie B et présentant des inhibiteurs du facteur IX.] [English, French abstract] (apre una nuova finestra)

Chau A, Wu J, Ansermino M, Tredwell S, Purdy R.

Fonte‎: Can J Anaesth 2008;55(1):47-51.

Indicizzato‎: PubMed 18166748

DOI‎: 10.1007/BF03017597

https://www.ncbi.nlm.nih.gov/pubmed/18166748 (apre una nuova finestra)

Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients. (apre una nuova finestra)

Guzzetta NA, Russell IA, Williams GD.

Fonte‎: Anesth Analg 2012;115(2):364-78.

Indicizzato‎: PubMed 22652310

DOI‎: 10.1213/ANE.0b013e31825aff10

https://www.ncbi.nlm.nih.gov/pubmed/22652310 (apre una nuova finestra)

The use of rFVIIa in non-haemophilia bleeding conditions in paediatrics. A systematic review. (apre una nuova finestra)

Mathew P.

Fonte‎: Thromb Haemost 2004;92(4):738-46.

Indicizzato‎: PubMed 15467904

DOI‎: 10.1160/TH04-03-0163

https://www.ncbi.nlm.nih.gov/pubmed/15467904 (apre una nuova finestra)

Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. (apre una nuova finestra)

Pychyńska-Pokorska M, Pągowska-Klimek I, Krajewski W, Moll JJ.

Fonte‎: J Cardiothorac Vasc Anesth 2011;25(6):987-94.

Indicizzato‎: PubMed 21835642

DOI‎: 10.1053/j.jvca.2011.05.012

https://www.ncbi.nlm.nih.gov/pubmed/21835642 (apre una nuova finestra)

Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery. (apre una nuova finestra)

Singh SP, Chauhan S, Choudhary M, Vasdev S, Talwar S.

Fonte‎: Asian Cardiovasc Thorac Ann 2012;20(1):19-23.

Indicizzato‎: PubMed 22371937

DOI‎: 10.1177/0218492311432584

https://www.ncbi.nlm.nih.gov/pubmed/22371937 (apre una nuova finestra)

Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (apre una nuova finestra)

Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.

Fonte‎: Pediatr Hematol Oncol 2008;25(4):301-11.

Indicizzato‎: PubMed 18484474

DOI‎: 10.1080/08880010802016904

https://www.ncbi.nlm.nih.gov/pubmed/18484474 (apre una nuova finestra)

Off-label use of rFVIIa in children with excessive bleeding: a consecutive study of 153 off-label uses in 139 children. (apre una nuova finestra)

Young G, Wicklund B, Neff P, Johnson C, Nugent DJ.

Fonte‎: Pediatr Blood Cancer 2009;53(2):179-83.

Indicizzato‎: PubMed 19415741

DOI‎: 10.1002/pbc.22053

https://www.ncbi.nlm.nih.gov/pubmed/19415741 (apre una nuova finestra)

Emergent pediatric anticoagulation reversal using a 4-factor prothrombin complex concentrate. (apre una nuova finestra)

Adams CB, Vollman KE, Leventhal EL, Acquisto NM.

Fonte‎: Am J Emerg Med 2016;34(6):1182.e1-2.

Indicizzato‎: PubMed 26652577

DOI‎: 10.1016/j.ajem.2015.10.041

https://www.ncbi.nlm.nih.gov/pubmed/26652577 (apre una nuova finestra)

Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (apre una nuova finestra)

Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F, Wang Y, Liu J.

Fonte‎: Artif Organs 2010;34(11):955-60.

Indicizzato‎: PubMed 21092037

DOI‎: 10.1111/j.1525-1594.2010.01148.x

https://www.ncbi.nlm.nih.gov/pubmed/21092037 (apre una nuova finestra)

Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery. A retrospective review. (apre una nuova finestra)

Faraoni D, Willems A, Savan V, Demanet H, De Ville A, Van der Linden P.

Fonte‎: Eur J Anaesthesiol 2014;31(6):317-26.

Indicizzato‎: PubMed 24503704

DOI‎: 10.1097/EJA.0000000000000043

https://www.ncbi.nlm.nih.gov/pubmed/24503704 (apre una nuova finestra)

Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial. (apre una nuova finestra)

Galas FR, de Almeida JP, Fukushima JT, Vincent JL, Osawa EA, Zeferino S, Câmara L, Guimarães VA, Jatene MB, Hajjar LA.

Fonte‎: J Thorac Cardiovasc Surg 2014;148(4):1647-55.

Indicizzato‎: PubMed 24951020

DOI‎: 10.1016/j.jtcvs.2014.04.029

https://www.ncbi.nlm.nih.gov/pubmed/24951020 (apre una nuova finestra)

Four-factor prothrombin complex concentrates in paediatric patients—a retrospective case series. (apre una nuova finestra)

Noga T, Bruce AA, Blain H, Nahirniak S.

Fonte‎: Vox Sang 2016;110(3):253-7.

Indicizzato‎: PubMed 26509839

DOI‎: 10.1111/vox.12353

https://www.ncbi.nlm.nih.gov/pubmed/26509839 (apre una nuova finestra)

Anesthetic management in a pediatric patient with Noonan syndrome, mastocytosis, and von Willebrand disease: a case report. (apre una nuova finestra)

Macksey LF, White B.

Fonte‎: AANA J 2007;75(4):261-4.

Indicizzato‎: PubMed 17711156

https://www.ncbi.nlm.nih.gov/pubmed/17711156 (apre una nuova finestra)

Utility of Sonoclot analysis and tranexamic acid in tetralogy of Fallot patients undergoing intracardiac repair. (apre una nuova finestra)

Aggarwal V, Kapoor PM, Choudhury M, Kiran U, Chowdhury U.

Fonte‎: Ann Card Anaesth 2012;15(1):26-31.

Indicizzato‎: PubMed 22234018

DOI‎: 10.4103/0971-9784.91477

https://www.ncbi.nlm.nih.gov/pubmed/22234018 (apre una nuova finestra)

Perioperative bleeding management in pediatric patients. (apre una nuova finestra)

Goobie SM, Haas T.

Fonte‎: Curr Opin Anaesthesiol 2016;29(3):352-8.

Indicizzato‎: PubMed 26844864

DOI‎: 10.1097/ACO.0000000000000308

https://www.ncbi.nlm.nih.gov/pubmed/26844864 (apre una nuova finestra)

Management of dilutional coagulopathy during pediatric major surgery. (apre una nuova finestra)

Haas T, Mauch J, Weiss M, Schmugge M.

Fonte‎: Transfus Med Hemother 2012;39(2):114-9.

Indicizzato‎: PubMed 22670129

DOI‎: 10.1159/000337245

https://www.ncbi.nlm.nih.gov/pubmed/22670129 (apre una nuova finestra)

Higher fibrinogen concentrations for reduction of transfusion requirements during major paediatric surgery: a prospective randomised controlled trial. (apre una nuova finestra)

Haas T, Spielmann N, Restin T, Seifert B, Henze G, Obwegeser J, Min K, Jeszenszky D, Weiss M, Schmugge M.

Fonte‎: Br J Anaesth 2015;115(2):234-43.

Indicizzato‎: PubMed 25982134

DOI‎: 10.1093/bja/aev136

https://www.ncbi.nlm.nih.gov/pubmed/25982134 (apre una nuova finestra)

Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. (apre una nuova finestra)

Nakayama Y, Nakajima Y, Tanaka KA, Sessler DI, Maeda S, Iida J, Ogawa S, Mizobe T.

Fonte‎: Br J Anaesth 2015;114(1):91-102.

Indicizzato‎: PubMed 25303988

DOI‎: 10.1093/bja/aeu339

https://www.ncbi.nlm.nih.gov/pubmed/25303988 (apre una nuova finestra)

Cardiac surgery without blood products in a Jehovah's Witness child with factor VII deficiency. (apre una nuova finestra)

Pérez-Ferrer A, Gredilla E, de Vicente J, Laporta Y.

Fonte‎: J Cardiothorac Vasc Anesth 2012;26(4):651-3.

Indicizzato‎: PubMed 21924639

DOI‎: 10.1053/j.jvca.2011.07.012

https://www.ncbi.nlm.nih.gov/pubmed/21924639 (apre una nuova finestra)

Activated coagulation time vs. intrinsically activated modified rotational thromboelastometry in assessment of hemostatic disturbances and blood loss after protamine administration in elective cardiac surgery: analysis from the clinical trial (NCT01281397). (apre una nuova finestra)

Petricevic M, Biocina B, Milicic D, Svetina L, Boban M, Lekić A, Konosic S, Milosevic M, Gasparovic H.

Fonte‎: J Cardiothorac Surg 2014;9:129.

Indicizzato‎: PubMed 25231271

DOI‎: 10.1186/1749-8090-9-129

https://www.ncbi.nlm.nih.gov/pubmed/25231271 (apre una nuova finestra)